What are David P. Hochman’s direct share holdings in Orchestra BioMed (OBIO) after this filing?

Following the tax-withholding transactions, David P. Hochman holds 1,060,746 shares of Common Stock directly. This figure reflects his remaining direct ownership after 3,283 shares were withheld to cover tax obligations tied to RSU vesting.

What does the RSU-related footnote in the Orchestra BioMed (OBIO) Form 4 explain?

The footnote explains that shares were withheld solely to satisfy tax obligations from restricted stock unit vesting. It clarifies that no shares were sold in the market as a result of the RSU vesting or the associated tax-withholding transactions reported.

Orchestra BioMed (OBIO) insider uses 6,566 shares to cover RSU taxes

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Orchestra BioMed Holdings, Inc. director and officer David P. Hochman reported routine equity compensation activity tied to vesting of restricted stock units. On June 10, 2026, the issuer withheld a total of 6,566 shares of Common Stock at $4.02 per share to satisfy tax withholding obligations, with no shares sold in the market.

After these tax-withholding dispositions, Hochman holds 1,060,746 Common Stock shares directly and 436,199 shares indirectly through the DPH 2008 Trust, along with additional indirect holdings in several family trusts holding between 2,000 and 3,140 shares each.

Insider Trade Summary

6 transactions reported

Mixed 6 txns

Insider Hochman David P

Role See Remarks

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock, par value $0.0001 per share ("Common Stock")	3,283	$4.02	$13K
Tax Withholding	Common Stock	3,283	$4.02	$13K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock, par value $0.0001 per share ("Common Stock") — 1,060,746 shares (Direct, null); Common Stock — 436,199 shares (Indirect, By the DPH 2008 Trust)

Footnotes (1)

[object Object]

Key Figures

Tax-withheld shares: 6,566 shares Tax-withholding price: $4.02 per share Direct holdings after transaction: 1,060,746 shares +3 more

6 metrics

Tax-withheld shares 6,566 shares Shares withheld to satisfy RSU tax obligations on June 10, 2026

Tax-withholding price $4.02 per share Value used for RSU-related tax-withholding dispositions

Direct holdings after transaction 1,060,746 shares Common Stock held directly by Hochman after tax withholding

DPH 2008 Trust holdings 436,199 shares Common Stock held indirectly via the DPH 2008 Trust after transaction

NSH 2008 Family Trust holdings 3,140 shares Indirect Common Stock holdings via NSH 2008 Family Trust

Judah Herman Hochman 2019 Trust 2,000 shares Indirect Common Stock holdings after reported date

Key Terms

restricted stock units ("RSUs"), tax withholding obligations, tax-withholding disposition, indirect ownership

4 terms

restricted stock units ("RSUs") financial

"in connection with vesting of restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

tax withholding obligations financial

"withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting"

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

indirect ownership financial

""ownership_type": "indirect", "ownership_code": "I""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/12/2026 - 04:16 PM Accepted by SEC EDGAR 06/12/2026 - 04:15 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hochman David P

(Last)

(First)

(Middle)

C/O ORCHESTRA BIOMED HOLDINGS, INC.

150 UNION SQUARE DRIVE

(Street)

NEW HOPE

PENNSYLVANIA

18938

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Orchestra BioMed Holdings, Inc. [ OBIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.0001 per share ("Common Stock")	06/10/2026		F⁽¹⁾		3,283	D	$4.02	1,060,746	D
Common Stock	06/10/2026		F⁽¹⁾		3,283	D	$4.02	436,199	I	By the DPH 2008 Trust
Common Stock								2,000	I	By the Solomon Ascher Hochman 2019 Trust
Common Stock								2,000	I	By the Hannah Hochman 2019 Trust
Common Stock								2,000	I	By the Judah Herman Hochman 2019 Trust
Common Stock								3,140	I	By the NSH 2008 Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

Remarks:

Chief Executive Officer and Chairperson

	/s/ Andrew Taylor, Attorney-in-Fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider activity did Orchestra BioMed (OBIO) report for David P. Hochman?

David P. Hochman reported tax-related share dispositions only. The issuer withheld 6,566 Common Stock shares upon RSU vesting to cover tax obligations, with no market sales, leaving his overall ownership position largely unchanged and still substantial.

How many Orchestra BioMed (OBIO) shares were withheld for taxes in this Form 4?

A total of 6,566 Common Stock shares were withheld to satisfy tax obligations. The shares were valued at $4.02 each and were taken from both direct holdings and the DPH 2008 Trust, with no open-market sale involved.

Does this Orchestra BioMed (OBIO) Form 4 show any open-market insider sales?

No, the Form 4 does not show open-market sales. It records only tax-withholding dispositions related to RSU vesting, and the footnote explicitly states no shares were sold in the market as part of this transaction.

What indirect Orchestra BioMed (OBIO) holdings does David P. Hochman report?

Indirectly, Hochman reports 436,199 Common Stock shares held by the DPH 2008 Trust, plus smaller positions in several family trusts. These additional trusts hold 3,140, 2,000, 2,000, and 2,000 shares respectively, reflecting long-term family-related ownership structures.